Chloroquine Current Events | Chloroquine News
|
|
|
Sort By:
Page Views | Date |
SARS antiviral drug discovered: traditional antimalarial drug works against SARS coronavirus infection
Virologists from the Katholieke Universiteit Leuven (K.U.Leuven) in Belgium report that chloroquine, a widely used antimalarial drug, exhibits antiviral activity against the SARS coronavirus. Chloroquine is an inexpensive and safe drug available worldwide. SARS (Severe Acute Respiratory Syndrome) is a respiratory illness which was first... view more... (2004-09-03)
Cellular antacids give vaccines a boost
Scientists in Italy have found that a drug that blocks acid buildup inside cells revs up the immune response to vaccines. view more (2005-09-12)
Therapeutic effect of imatinib improved with addition of chloroquine
The therapeutic effects of the blockbuster leukemia drug imatinib may be enhanced when given along with a drug that inhibits a cell process called autophagy, researchers from the Kimmel Cancer Center at Jefferson reported in the Journal of Clinical Investigation. view more (2009-04-14)
Funding and distribution of inappropriate drugs contributing to increasing global childhood death from malaria (p 237)
'Institutional inadequacies' of the World Health Organization (WHO) and the Global Fund for Aids, tuberculosis, and Malaria (GFATM) have created a crisis which is leading to increased malarial deaths in children and will contribute to the failure of WHO's 1998 'Roll Back Malaria' campaign to halve deaths from malaria by 2010, conclude authors of... view more... (2004-01-14)
Fresh Hopes For Treatment Of Malaria In Africa (p 1218)
Despite the large number of deaths caused worldwide by AIDS, tuberculosis, and diarrhoeal diseases such as cholera, the biggest infectious-disease killer is still malaria, especially in Africa. Efforts to eradicate the carrier of malaria, a mosquito, have been only partly successful. The standard treatment for malaria has, for many years, been... view more... (2001-10-10)
Binghamton University researchers investigate evolving malaria resistance
Funded by a $1.5 million grant from the National Institutes of Health, scientists at Binghamton University, State University of New York, hope to understand how the malaria parasite Plasmodium falciparum evolved resistance to the once-effective medication chloroquine. view more (2007-08-30)
Drug blocks 2 of world's deadliest emerging viruses
Two highly lethal viruses that have emerged in recent outbreaks are susceptible to chloroquine, an established drug used to prevent and treat malaria, according to a new basic science study by researchers at Weill Cornell Medical College in the Journal of Virology. view more (2009-03-06)
Common cause of heart disease, diabetes may be treatable with malaria drug
Studies of a rare genetic condition that increases cancer risk have unveiled a potential treatment for metabolic syndrome, a common disorder that afflicts as many as one in every four American adults and puts them at sharply increased risk of type 2 diabetes and clogged arteries. view more (2006-11-08)
Ugandan Study Highlights Best Drug Combinations For Treating Malaria In Africa (pp 1922, 1950)
ISSUE: 27 November-3 December 2004 EMBARGO: 0001 H (London time) Friday 26 November 2004. In North America the embargo lifts at 6.30pm ET Thursday 25 November 2004. view more (2004-11-24)
False or pirated antimalarial drugs freely obtainable in Cameroon
Large-scale diffusion and sale of medicines that do not comply with regulations or are poor in quality, especially in African countries, stems from several factors. These include: the intensification of trade, a growing demand for medical treatments or vaccines, a proliferation of small pharmaceutical industries, and inadequate regulation of... view more... (2004-05-18)
New links in the cystic fibrosis chain uncover potential therapeutics
Cystic fibrosis (CF) is an inherited disease caused by mutations in the CFTR gene. Each mutation has number of effects on the cells of the lungs. view more (2007-10-19)
Unique immunization method provides insights about protective anti-malaria immune response
In this week's New England Journal of Medicine, scientists in Singapore, The Netherlands and France report that they have developed a novel immunization method that will induce fast and effective protection in humans against the life-threatening malaria parasite, Plasmodium falciparum, which infects 350 to 500 million people world-wide and kills... view more... (2009-07-31)
Passenger Screening Advised To Cut Risk Of Importing Drug-Resistant Malaria To Africa
Imported resistance has rendered ineffective the two affordable malaria drugs which have been the mainstay of malaria treatment in Africa for forty years, according to experts writing today in the journal Science. Scientists from the London School of Hygiene and Tropical Medicine and colleagues from institutions in the USA, South Africa and... view more... (2004-08-16)
Dramatic fall in malaria in the Gambia raises possibility of elimination in parts of Africa
The incidence of malaria has fallen significantly in The Gambia in the last 5 years, according to a study carried out by experts there with support from scientists based in London. view more (2008-10-31)
Malaria: Efficacy of monotherapies in Cameroon
Malaria, which affects about 600 millions people in the world, is the most widespread of the transmissible parasitic diseases. The causative agent is a microscopic parasite of the genus Plasmodium. view more (2006-10-16)
Why are the best malaria drugs not being used in Africa?
Despite changes in policy in many African countries, most cases of malaria are still treated with old drugs that often fail, say researchers in this week's BMJ. view more (2005-09-30)
New Treatment Option For Children With Malaria (p 1365)
Combination of the drugs artesunate and amodiaquine could be a new treatment option for children with malaria caused by the parasite Plasmodium falciparum, conclude authors of a fast-track study in this week's issue of THE LANCET. Drug-resistant P. falciparum malaria is a serious problem in sub-Saharan Africa. Chloroquine resistance is a major... view more... (2002-04-17)
A new approach to the treatment of malaria in pregnant women in West Africa
A new approach to treatment for pregnant women suffering from malaria in west Africa has been found to be both safe and effective, following a randomised trial carried out by a team based in Ghana and at the London School of Hygiene & Tropical Medicine (LSHTM). view more (2006-10-13)
Largest synthetic gene ever built offers insights into anti-malarial drug resistance
Researchers at Georgetown University Medical Center say they are moving closer to understanding why the most lethal form of human malaria has become resistant to drug treatment in the past three decades. view more (2007-06-07)
Heeding the WARNing from malaria's past
A global network to monitor drug resistance and guide malaria treatment and prevention policies is being launched. view more (2007-09-06)
|
|
|
|
Sort By:
Page Views | Date |
|
